NM_000143.4:c.1370_1371insTCAC
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000143.4(FH):c.1370_1371insTCAC(p.Ala458HisfsTer10) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. T457T) has been classified as Likely benign.
Frequency
Consequence
NM_000143.4 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FH | NM_000143.4 | c.1370_1371insTCAC | p.Ala458HisfsTer10 | frameshift_variant | Exon 9 of 10 | ENST00000366560.4 | NP_000134.2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not provided Pathogenic:2
The c.1370_1371insTCAC pathogenic variant in the FH gene causes a frameshift starting with codon Alanine 458, changes this amino acid to a Histidine residue and creates a premature Stop codon at position 10 of the new reading frame, denoted p.Ala458HisfsX10. This pathogenic variant is predicted to cause loss of normal protein function through protein truncation due to the last 53 amino acids being replaced by 9 aberrant amino acids. Although this pathogenic variant has not been previously reported to our knowledge, its presence is consistent with a diagnosis of hereditary leiomyomatosis and renal cell cancer (HLRCC). The variant is found in FH panel(s). -
This variant is not present in population databases (gnomAD no frequency). For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the FH protein in which other variant(s) (p.Trp500*) have been determined to be pathogenic (PMID: 9635293, 20549362, 21398687). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 214405). This premature translational stop signal has been observed in individual(s) with clinical features of FH-related conditions (Invitae). This sequence change creates a premature translational stop signal (p.Ala458Hisfs*10) in the FH gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 53 amino acid(s) of the FH protein. -
Hereditary leiomyomatosis and renal cell cancer Pathogenic:1
This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation. -
Fumarase deficiency Pathogenic:1
- -
Hereditary cancer-predisposing syndrome Pathogenic:1
The c.1370_1371insTCAC pathogenic mutation, located in coding exon 9 of the FH gene, results from an insertion of 4 nucleotides at position 1370, causing a translational frameshift with a predicted alternate stop codon (p.A458Tfs*10). This alteration occurs at the 3' terminus of theFH gene, is not expected to trigger nonsense-mediated mRNA decay, and only impacts the last 53 amino acids of the protein. However, premature stop codons are typically deleterious in nature and the impacted region is critical for protein function (Ambry internal data). This alteration has been observed in at least one individual who has a personal or family history that is consistent with FH-associated disease (Ambry internal data). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at